Nextgen Biologics
Manufacturing · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
218 NW 2nd Ave, Gainesville, Florida, 32...Phone Number
(904) 599-3264Website
www.nextgenbiologics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Nextgen Biologics
NeXtGen Biologics Inc. is revolutionizing regenerative medicine with its innovative technology based on the axolotl, a species renowned for its regenerative capabilities. Their flagship product, NeoMatriX, is a collagen wound matrix derived from the axolotl's extracellular matrix, designed to aid in the management of various wound types. The company targets healthcare providers and professionals in the field of wound care, showcasing their advancements at industry conferences. NeXtGen Biologics aims to enhance patient outcomes through cutting-edge solutions in wound healing.Explore more
Nextgen Biologics Org Chart
JM
Senior Manager, Operations
JO
Manager, Raw Materials Facility
DS
Manager, Raw Material Facility
VE
Supervisor, Manufacturing
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nextgen Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Nextgen Biologics is spiking on competitors!
Nextgen Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Nextgen Biologics recently announced quarterly report
Check if Nextgen Biologics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Nextgen Biologics has new funding data
Product Launch: Get notified when Nextgen Biologics launches new products
Website visits: Recent activity has been detected on your website
Click to see if Nextgen Biologics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Nextgen Biologics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Nextgen Biologics
Compare insights from companies similar to Nextgen Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$9.3M
11-50
Private
$115M
2010
AK
Alexander KhairkhahanInventor, Founder, Chief Operating Officer, General Manager
Company Profile Activity
Activity Insights
Nextgen Biologics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nextgen Biologics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nextgen Biologics.
Nextgen Biologics financials insights
Gather financial insights about Nextgen Biologics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2025
Private Equity
$130K
Nextgen Biologics Tech Stack
A closer look at the technologies used by Nextgen Biologics
Nextgen Biologics News & Media
NeXtGen Biologics and Lovell® Government Services Partner to Bring Innovative Advanced Wound Care Technology to Federal Healthcare Systems
NeXtGen Biologics and Lovell® Government Services Partner to Bring Innovative Advanced Wound Care Technology to Federal Healthcare SystemsNeXtGen Biologics Successfully Completes First FDA Audit with Zero 483 Observations
NeXtGen Biologics Successfully Completes First FDA Audit with Zero 483 ObservationsNeXtGen Biologics Announces Issuance Of A Third New Patent Covering Axolotl-Derived Technology
NeXtGen Biologics Announces Issuance Of A Third New Patent Covering Axolotl-Derived Technology
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nextgen Biologics
Sign Up For FreeTo access detailed company insights
NeXtGen Biologics Inc. is revolutionizing regenerative medicine with its innovative technology based on the axolotl, a species renowned for its regenerative capabilities. Their flagship product, NeoMatriX, is a collagen wound matrix derived from the axolotl's extracellular matrix, designed to aid in the management of various wound types. The compan... Read More
